Shares of VBI Vaccines Inc. (TSE:VBV – Get Free Report) were down 5.1% on Wednesday . The stock traded as low as C$4.82 and last traded at C$4.82. Approximately 1,300 shares changed hands during trading, a decline of 64% from the average daily volume of 3,637 shares. The stock had previously closed at C$5.08.
VBI Vaccines Trading Down 5.1 %
The company has a current ratio of 2.64, a quick ratio of 2.54 and a debt-to-equity ratio of 14.29. The company has a 50-day moving average of C$4.82. The firm has a market cap of C$308.86 million and a PE ratio of -4.97.
VBI Vaccines Company Profile
VBI Vaccines Inc, a biopharmaceutical company, develops and sells vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. The company offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborns; and eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines that closely mimic the target virus.
Read More
- Five stocks we like better than VBI Vaccines
- What is the Dogs of the Dow Strategy? Overview and Examples
- The Great CPU Race: AMD and Intel Battle for Dominance
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for VBI Vaccines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VBI Vaccines and related companies with MarketBeat.com's FREE daily email newsletter.
